FI54916B - FRAMEWORK FOR THERAPEUTIC TREATMENT OF NUTRITIONAL N-SUBSTITUTE 2-PYRROLIDONER - Google Patents
FRAMEWORK FOR THERAPEUTIC TREATMENT OF NUTRITIONAL N-SUBSTITUTE 2-PYRROLIDONERInfo
- Publication number
- FI54916B FI54916B FI383/71A FI38371A FI54916B FI 54916 B FI54916 B FI 54916B FI 383/71 A FI383/71 A FI 383/71A FI 38371 A FI38371 A FI 38371A FI 54916 B FI54916 B FI 54916B
- Authority
- FI
- Finland
- Prior art keywords
- pyrrolidoner
- nutritional
- substitute
- framework
- therapeutic treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB697870A GB1309692A (en) | 1970-02-13 | 1970-02-13 | N-substituted lactams |
Publications (2)
Publication Number | Publication Date |
---|---|
FI54916B true FI54916B (en) | 1978-12-29 |
FI54916C FI54916C (en) | 1979-04-10 |
Family
ID=9824325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI383/71A FI54916C (en) | 1970-02-13 | 1971-02-10 | FRAMEWORK FOR THERAPEUTIC TREATMENT OF NUTRITIONAL N-SUBSTITUTE 2-PYRROLIDONER |
Country Status (15)
Country | Link |
---|---|
JP (2) | JPS535301B1 (en) |
BE (1) | BE762728R (en) |
CH (1) | CH530395A (en) |
CS (2) | CS167911B2 (en) |
DE (1) | DE2106418C2 (en) |
DK (1) | DK137451B (en) |
ES (1) | ES388135A2 (en) |
FI (1) | FI54916C (en) |
FR (1) | FR2081508B2 (en) |
GB (1) | GB1309692A (en) |
MY (1) | MY7400072A (en) |
NL (1) | NL168830C (en) |
SU (2) | SU508186A3 (en) |
YU (2) | YU34876B (en) |
ZA (1) | ZA71877B (en) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1045043B (en) * | 1975-08-13 | 1980-04-21 | Isf Spa | PYROLIDINE DERIVATIVES |
GB1583871A (en) | 1976-10-19 | 1981-02-04 | Ucb Sa | Anti-aggregants |
BE864269A (en) * | 1977-03-03 | 1978-06-16 | Parke Davis & Co | NEW N- (AMINOALKYL SUBSTITUTE) -2-OXO-1-PYRROLIDINE-ACETAMIDES AND METHODS FOR PRODUCING THEM |
EP0005689B1 (en) | 1978-05-08 | 1981-03-18 | U C B, S.A. | Lactam-n-acetic acids, their amides, process for their preparation and therapeutic compositions containing them |
IT1141287B (en) * | 1979-06-13 | 1986-10-01 | Nattermann A & Cie | PYROLIDIN ACIDS AMIDS- (2) -ON- (1) -ILALKYL-CARBOXYLS, PROCEDURE FOR THEIR PREPARATION AND MEDICINAL PRODUCTS CONTAINING THEM |
FR2515179A1 (en) * | 1981-07-24 | 1983-04-29 | Hoffmann La Roche | PYRROLIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, INTERMEDIATES FOR THEIR SYNTHESIS AND THEIR THERAPEUTIC APPLICATION |
DE3361609D1 (en) * | 1982-03-24 | 1986-02-06 | Prodes Sa | New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts |
GB8412357D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
GB8412358D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
DE3420193A1 (en) * | 1984-05-30 | 1985-12-05 | Boehringer Ingelheim KG, 6507 Ingelheim | NEW SUBSTITUTED PYRROLIDINONES, METHOD FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS |
US4804400A (en) * | 1986-09-12 | 1989-02-14 | Ciba-Geigy Corporation | N-phenyl-maleimides and herbicidal and plant growth regulating methods of use thereof |
GB8827389D0 (en) * | 1988-11-23 | 1988-12-29 | Ucb Sa | Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
AR020115A1 (en) * | 1998-08-06 | 2002-04-10 | Daiichi Seiyaku Co | THERAPEUTIC OR PREVENTIVE AGENT FOR REBEL EPILEPSIES AND USE OF THE COMPOUND FOR THE SAME PRODUCTION |
GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
US6686477B2 (en) | 2000-09-29 | 2004-02-03 | Eastman Chemical Company | Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
WO2002094787A1 (en) | 2001-05-23 | 2002-11-28 | Ucb, S.A. | 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders |
AU2002329233B2 (en) | 2001-08-10 | 2007-08-16 | Ucb Pharma | Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues |
AU2002340971B2 (en) * | 2001-10-08 | 2007-04-26 | Ucb | Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders |
CN1802352A (en) | 2003-02-03 | 2006-07-12 | 特瓦制药工业有限公司 | Process for producing levetiracetam |
ES2214147B1 (en) | 2003-02-28 | 2005-10-01 | Farma-Lepori S.A. | PROCEDURE FOR OBTAINING AN ANTIEPILEPTIC AGENT. |
CA2497062A1 (en) | 2004-02-18 | 2005-08-18 | Dr. Reddy's Laboratories Limited | Preparation of amino acid amides |
CA2488325C (en) | 2004-11-22 | 2010-08-24 | Apotex Pharmachem Inc. | Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
US20080146819A1 (en) * | 2005-03-10 | 2008-06-19 | Rubamin Limited | Process for Preparing Levetiracetam |
EP1912966A2 (en) | 2005-06-01 | 2008-04-23 | Ucb, S.A. | 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system |
EP2147911A1 (en) | 2008-07-24 | 2010-01-27 | ZaCh System S.p.A. | Process for the preparation of levetiracetam |
ES2637497T3 (en) | 2008-10-16 | 2017-10-13 | The Johns Hopkins University | Procedures and compositions for the improvement of cognitive function |
WO2010132693A2 (en) | 2009-05-13 | 2010-11-18 | Nektar Therapeutics | Oligomer-containing pyrrolidine compounds |
US7939676B2 (en) | 2009-09-17 | 2011-05-10 | Zach System S.P.A. | Process for the preparation of levetiracetam |
WO2011100373A1 (en) | 2010-02-09 | 2011-08-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
JP6440625B2 (en) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | Methods and compositions for treating schizophrenia |
WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
CA2904767C (en) | 2013-03-15 | 2022-06-21 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
KR20200126026A (en) | 2014-01-21 | 2020-11-05 | 얀센 파마슈티카 엔.브이. | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
CN106061504B (en) | 2014-01-21 | 2019-09-06 | 詹森药业有限公司 | Positive allosteric modulator or the combination of normotopia agonist including metabotropic glutamate energy receptor subtype 2 and application thereof |
CN104059010A (en) * | 2014-06-12 | 2014-09-24 | 浙江华海药业股份有限公司 | Preparation method of 2-(2-oxopyrrolidine-1-yl)-butyrate |
CN106591179B (en) * | 2016-12-05 | 2018-07-03 | 长兴制药股份有限公司 | Methyl packing bacterium and its prepare the application on (S)-α-ethyl -2- oxygen -1- pyrrolidine acetic acid salt in selective fractionation |
RU2663899C1 (en) * | 2017-07-19 | 2018-08-13 | Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" | Process for the preparation of 1-carbamoylmethyl-4-phenyl-2-pyrrolidone |
US11384050B1 (en) | 2021-02-03 | 2022-07-12 | Vitaworks Ip, Llc | Method for preparing levetiracetam and intermediates thereof |
US20240132513A1 (en) | 2022-08-19 | 2024-04-25 | Agenebio, Inc. | Benzazepine derivatives, compositions, and methods for treating cognitive impairment |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1039113A (en) * | 1964-08-06 | 1966-08-17 | Ucb Sa | New n-substituted lactams |
-
1970
- 1970-02-13 GB GB697870A patent/GB1309692A/en not_active Expired
-
1971
- 1971-02-08 FR FR7104195A patent/FR2081508B2/fr not_active Expired
- 1971-02-09 NL NLAANVRAGE7101697,A patent/NL168830C/en not_active IP Right Cessation
- 1971-02-10 YU YU306/71A patent/YU34876B/en unknown
- 1971-02-10 FI FI383/71A patent/FI54916C/en active
- 1971-02-10 DK DK59571AA patent/DK137451B/en not_active IP Right Cessation
- 1971-02-10 BE BE762728A patent/BE762728R/en active
- 1971-02-10 ES ES388135A patent/ES388135A2/en not_active Expired
- 1971-02-10 CS CS987A patent/CS167911B2/cs unknown
- 1971-02-11 CH CH200171A patent/CH530395A/en not_active IP Right Cessation
- 1971-02-11 DE DE2106418A patent/DE2106418C2/en not_active Expired
- 1971-02-11 ZA ZA710877A patent/ZA71877B/en unknown
- 1971-02-12 SU SU1893858A patent/SU508186A3/en active
- 1971-02-12 JP JP612471A patent/JPS535301B1/ja active Pending
- 1971-02-12 SU SU1621307A patent/SU508185A3/en active
- 1971-12-10 CS CS140674A patent/CS167912B2/cs unknown
-
1974
- 1974-12-31 MY MY197472A patent/MY7400072A/en unknown
-
1977
- 1977-11-07 JP JP13335277A patent/JPS53130656A/en active Granted
-
1978
- 1978-06-19 YU YU01445/78A patent/YU144578A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JPS5420491B2 (en) | 1979-07-23 |
DE2106418A1 (en) | 1971-08-19 |
FR2081508B2 (en) | 1975-06-06 |
CS167911B2 (en) | 1976-05-28 |
CH530395A (en) | 1972-11-15 |
NL7101697A (en) | 1971-08-17 |
JPS53130656A (en) | 1978-11-14 |
FI54916C (en) | 1979-04-10 |
GB1309692A (en) | 1973-03-14 |
BE762728R (en) | 1971-08-10 |
DK137451B (en) | 1978-03-06 |
CS167912B2 (en) | 1976-05-28 |
SU508185A3 (en) | 1976-03-25 |
NL168830B (en) | 1981-12-16 |
YU144578A (en) | 1982-10-31 |
ZA71877B (en) | 1971-10-27 |
JPS535301B1 (en) | 1978-02-25 |
SU508186A3 (en) | 1976-03-25 |
DK137451C (en) | 1978-07-24 |
YU30671A (en) | 1979-10-31 |
FR2081508A2 (en) | 1971-12-03 |
MY7400072A (en) | 1974-12-31 |
DE2106418C2 (en) | 1983-12-22 |
YU34876B (en) | 1980-04-30 |
NL168830C (en) | 1982-05-17 |
ES388135A2 (en) | 1973-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI54916C (en) | FRAMEWORK FOR THERAPEUTIC TREATMENT OF NUTRITIONAL N-SUBSTITUTE 2-PYRROLIDONER | |
SE387861B (en) | APPARATUS FOR EVAPORATION TREATMENT OF VETSKOR | |
SE393381B (en) | ANALOGICAL PROCEDURE FOR THE PREPARATION OF 8-AZAPURIN - 6 - UNDERIVATIVES | |
FI54301C (en) | FRAMEWORK FOR THE PREPARATION OF THERAPEUTIC THERAPEUTIC KINAZOLINDERIVAT | |
SE400083B (en) | PROCEDURE FOR THE MANUFACTURE OF HUMAN CARCINOEMBRYONAL ANTIGEN | |
SE390304B (en) | ANALOGICAL PROCEDURE FOR THE PREPARATION OF 4-HYDROXY-5-ETHYL-6-PHONYLPYRIMIDINE | |
SE384529B (en) | APPLIANCE FOR TREATMENT OF ANIMAL SKIN OR SIMILAR | |
FI55184B (en) | PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC VERKSAMY PHENYL-2-PYRROLIDINONER SAMT DERAS ISOMERER | |
SE388422B (en) | PROCEDURE FOR REDUCTION OF THEABIN | |
BE776863A (en) | REDISTRIBUTION OF ALKYLHYDROSILANES | |
FI54100C (en) | FRAMEWORK FOR THERAPEUTIC TREATMENT OF THERAPEUTIC TRICYCLES | |
DOP1971001881A (en) | TREATMENT OF TEETH | |
FI54104C (en) | FRAMEWORK FOR THERAPEUTIC TREATMENT | |
FI54602C (en) | FRAMEWORK FOR THE PREPARATION OF THERAPEUTIC THERAPY OF 6-AMIDINOPENICILLANSYRADERIVAT | |
FI55988C (en) | REFERENCE FOR THERAPEUTIC USE OF THERAPEUTIC THERAPEUTIC O-ACYLPHENOLETHANOLAMINER | |
FI53967C (en) | FRAMEWORK FOR THERAPEUTIC ADJUSTMENT OF THERAPEUTIC BENSOBICYCLOALKANAMINER | |
FI55503C (en) | FRAMEWORK FOR THE PREPARATION OF THERAPEUTIC ANIMAL THERMAL PYRIMIDINONDERIVAT | |
SE384142B (en) | TREATMENT CHAMBER | |
FI53700C (en) | FRAMEWORK FOR THE ADMINISTRATION OF THERAPEUTIC THERAPEUTIC DIAMINOPROPIOFENONDERIVAT | |
FI53819C (en) | FORMULATION OF NUTRITIONAL THERAPEUTIC NUTRITIONAL N-LYSERGYL-3-AMINOPYRIDINER | |
FI55338C (en) | PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC VERIFICATION N-METHYL IMIDAZOLER | |
SE382051B (en) | PROCEDURE FOR PREPARATION OF 3-SULPHONAMIDE-4-HYDROXYPHENYL-2-PIPERIDYLCARBINOLS | |
FI56171B (en) | FRAMEWORK FOR THE PREPARATION OF THERAPEUTIC ACTIVATED ACYLES | |
FI56179C (en) | ADJUSTMENT OF THERAPEUTIC FREQUENCY OF THERAPEUTIC | |
BE774241A (en) | THERAPEUTIC PROCESS AND COMPOSITIONS |